PTK2 and Alzheimer disease: Tyrosine phosphorylation and activation of FAK are observed in AD patient brains and in primary cortical cultures treated with Aβ oligomers, where it cooperates with Fyn and PI3K to activate MAPK, indicating that FAK-mediated signaling may contribute to AD pathology.